Literature DB >> 10943503

Surgical treatment of the child's and adolescent's flexible flatfoot.

D P Roye1, R A Raimondo.   

Abstract

Operative intervention for juvenile flexible flatfoot is considered after a protracted course of orthotics and shoe modifications have failed to relieve associated symptoms. Surgical treatment options include hindfoot fusion, soft tissue procedures, calcaneal osteotomies, limited midtarsal arthrodeses, combination techniques, and subtalar arthroereisis. Long-term, high success rates have been documented with use of combination procedures and the anterior calcaneal osteotomy of Evans.

Entities:  

Mesh:

Year:  2000        PMID: 10943503

Source DB:  PubMed          Journal:  Clin Podiatr Med Surg        ISSN: 0891-8422            Impact factor:   1.231


  5 in total

1.  Pediatric flexible flatfoot; clinical aspects and algorithmic approach.

Authors:  Farzin Halabchi; Reza Mazaheri; Maryam Mirshahi; Ladan Abbasian
Journal:  Iran J Pediatr       Date:  2013-06       Impact factor: 0.364

2.  Surgical treatment results for flexible flatfoot in adolescents.

Authors:  Necip Selcuk Yontar; Tahir Ogut; Mehmet Fatih Guven; Huseyin Botanlioglu; Gokhan Kaynak; Ata Can
Journal:  Acta Orthop Traumatol Turc       Date:  2016-11-11       Impact factor: 1.511

Review 3.  Key concepts in children's footwear research: a scoping review focusing on therapeutic footwear.

Authors:  Matthew Hill; Aoife Healy; Nachiappan Chockalingam
Journal:  J Foot Ankle Res       Date:  2019-04-27       Impact factor: 2.303

4.  Effectiveness of surgically treated symptomatic plano-valgus deformity by the calcaneo stop procedure according to radiological, functional and gait parameters.

Authors:  Sakti P Das; Pulin B Das; Ganesh S; Mahesh C Sahu
Journal:  J Taibah Univ Med Sci       Date:  2017-01-13

5.  Is it possible to define reference values for radiographic parameters evaluating juvenile flatfoot deformity? A case-control study.

Authors:  Johannes Hamel; Hubert Hörterer; Norbert Harrasser
Journal:  BMC Musculoskelet Disord       Date:  2020-12-11       Impact factor: 2.362

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.